The accuracy of PD-L1 expression in predicting the effectiveness of PD-L1/PD-1 + Chemo in SCLC is low, although it has been considered a possible prognostic biomarker of response to ICIs in various tumor types [14, 23]. The gene discussed is CD274; the disease is neoplasm.